Anti-malarial compound passes first stage of preclinical efficacy study

摘要

A mosquito-borne infectious disease that results from red-blood cells being overrun by parasites of the Plasmodium genus, malaria kills about one million people annually."About 90 percent of all deaths worldwide are caused by the protozoan parasite Plasmodium falciparum," says principal scientist Dr Gary Evans from IRL's Carbohydrate Chemistry group."Early efficacy trials have shown that BCX4945 clears the parasite responsible for malaria within seven days," he said.